Table 2—
Number of beneficiaries, average annual medical cost per person, and percentage of beneficiaries among Medicare fee-for-service population with type 2 diabetes by diabetes complication
| Complication | Beneficiaries, n | Unadjusted mean annual cost, 2017 U.S. $ | Percentage of beneficiaries |
|---|---|---|---|
| Nephropathy Subsequent years |
2,647,151 3,879,087 |
41,793 30,257 |
33.1 48.5 |
| Kidney failure treated by transplant Subsequent years |
3,753 5,839 |
123,013 44,731 |
0.1 0.1 |
| Kidney failure treated by dialysis Subsequent years |
192,824 211,024 |
110,821 85,809 |
2.4 2.6 |
| Neuropathy Subsequent years |
1,558,717 2,527,684 |
34,453f 28,238 |
19.5 31.6 |
| LEA Subsequent years |
63,358 39,575 |
103,889 41,000 |
0.8 0.5 |
| Chronic retinopathy Subsequent years |
562,539 1,131,758 |
27,306 27,817 |
7.0 14.1 |
| Blindness and vision loss Subsequent years |
504,414 603,464 |
44,082 32,789 |
6.3 7.5 |
| CHF Subsequent years |
2,197,008 3,398,735 |
48,869 33,634 |
27.4 42.5 |
| Foot ulcer Subsequent years |
1,184,493 1,531,470 |
48,555 32,947 |
14.8 19.1 |
| MI Subsequent years |
1,140,526 1,457,014 |
63,737 28,963 |
14.2 18.2 |
| Stroke Subsequent years |
2,191,709 1,537,212 |
45,903 26,822 |
27.4 19.2 |
| Angina Subsequent years |
1,205,134 862,158 |
38,618 23,368 |
15.1 10.8 |
| Revascularization Subsequent years |
1,405,376 596,626 |
43,256 20,180 |
17.6 7.5 |
| Retinopathy intravitreal injections | 347,572 | 29,476 | 4.3 |
| Photocoagulation | 373,517 | 33,493 | 4.7 |
| Hypoglycemia | 739,495 | 50,638 | 9.2 |
| Ketoacidosis | 16,767 | 55,447 | 0.2 |